Načítá se...

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

INTRODUCTION: An Alzheimer's disease (AD) biomarker adjusted for age-related brain changes should improve specificity for AD-related pathological burden. METHODS: We calculated a brain-age-adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients from the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Dement (Amst)
Hlavní autoři: Racine, Annie M., Brickhouse, Michael, Wolk, David A., Dickerson, Bradford C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956936/
https://ncbi.nlm.nih.gov/pubmed/29780874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.02.007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!